D. E. Shaw & Co., Inc.

Position in SLDB — Solid Biosciences Inc.

CIK 1009207 New York, NY

Position in SLDB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,225,662

+$1,301,557 QoQ

Shares Held

222,789

+73.6% QoQ

Ownership

0.208%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 155 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. SLDB ranks #127 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,225,662	222,789	+73.6%	Shares	Defined	2026-08-14
2026-03-31	$924,105	128,348	+0.1%	Shares	Defined	2026-05-15
2025-12-31	$723,386	128,260	+146.8%	Shares	Defined	2026-02-17
2024-12-31	$207,888	51,972	+164.0%	Shares	Defined	2025-02-14
2021-09-30	$47,051	19,687	-71.1%	Shares	Defined	2021-11-15
2021-06-30	$249,213	68,091	+313.1%	Shares	Defined	2021-08-16
2021-03-31	$91,150	16,483	-92.7%	Shares	Defined	2021-05-17
2020-12-31	$1,715,877	226,369	-22.9%	Shares	Defined	2021-02-16
2020-09-30	$595,869	293,532	-18.1%	Shares	Defined	2020-11-16
2020-06-30	$1,050,205	358,432	+17.0%	Shares	Defined	2020-08-14
2020-03-31	$732,104	306,320	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.